Not another innovation
نویسندگان
چکیده
منابع مشابه
'Not another UTI ... '.
Malaria includes a global disease burden with approximately 300-500 million cases worldwide annually. Varied symptomatology creates a diagnostic challenge. This is a case report of a stroke rehabilitation facility resident who developed Plasmodium ovale infection, several months post-exposure. Physicians should maintain a broad list of differential diagnoses, thinking beyond the range of common...
متن کاملDefinitely NOT Just another Hernia
A 77-year-old male presented to our emergency department (ED) with a 3-hour history of acute severe lower abdominal pain, inability to void, a swollen scrotum, and one episode of vomiting. His relevant past medical history included: hypertension, diabetes mellitus, and distant right inguinal hernia repair. Vital signs were: 96.40 F, 101, 22, and 205/90. Examination revealed a normal abdomen and...
متن کاملAggregate litigation and regulatory innovation: Another view of judicial efficiency
In this article, we argue that aggregate litigation and the court system can not only restore the protection of victims and the production of deterrence, but also play a pivotal role in stimulating regulatory innovation. This is accomplished through a reward system that seems largely to mimic the institutional devices used in other domains, such as intellectual property rights, by defining a pr...
متن کاملAdoption Timing of New Equipment with Another Innovation Anticipated
In dynamic environments, decisions about adopting or replacing new equipment or processes are influenced by the expectation of further innovations in technology. This paper examines the issue of the time at which an equipment (vintage one) currently in use is to be replaced with better equipment (vintage two), in the face of uncertain future availability of even better equipment (vintage three)...
متن کاملDoxofylline is not just another theophylline!
Doxofylline, which differs from theophylline in containing the dioxalane group at position 7, has comparable efficacy to theophylline in the treatment of respiratory diseases, but with an improved tolerability profile and a favorable risk-to-benefit ratio. Furthermore, it does not have significant drug-drug interactions as exhibited with theophylline, which make using theophylline more challeng...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2006
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.332.7545.847